You know, listen, there is no place in the United States of America where two, three, four hour waits to vote is acceptable. And just because it's happening in a blue state doesn't mean that it's not voter suppression.
Alexandria Ocasio-Cortez
The Public Record
Alexandria Ocasio-Cortez is an American politician and activist serving as the U.S. Representative for New York's 14th congressional district since January 3, 2019. A member of the Democratic Party, she gained national attention for her progressive policies and advocacy on issues such as climate change, healthcare, and economic inequality. Ocasio-Cortez is known for her grassroots campaigning and her ability to mobilize young voters, making her a prominent figure in the progressive wing of the party.
the American people by almost a 3 to 1 margin prefer for Congress to work on a new COVID relief measure before the election rather than trying to install the new judge on the Supreme Court.
The president and the Republican Party are walking away from getting any COVID stimulus relief done, effectively endangering millions after they themselves got COVID and enjoyed free socialized health care, also they can push through an…
Not only that, but he's also directly conflicting himself today. He retweeted the Federal Chairman Jerome Powell, which is saying that Congress cannot do enough when it comes to critical economic indicators like inflation, when it looks at…
There is -- the Fed is basically telling us that there is no program too big that we could authorize. We cannot effectively spend enough right now.
This is also about Lindsey Graham. This is about Mitch McConnell. This is about Susan Collins.
Now, if we decide and if the president and the GOP follow through with walking away from COVID relief, we are looking at one of -- we are staring down the barrel at one of the largest mass eviction crises in the history of this country…
But that is quite all right, thank you. Thankfully, we do know, and the answer is that it was.
And while Teva was forced to put pressure, was forced to lower the price in Europe, in that same two-year period, the company raised the price on U.S. multiple sclerosis patients by 60 percent.
So, Mr. Schultz, why is the price of Copaxone so much higher for people with multiple sclerosis in the United States than those in other countries?





